Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies

Pepper, Andrea G S, Zucchetto, Antonella, Norris, Kevin, Tissino, Erika, Polesel, Jerry, Soe, Zarni, Allsup, David, Hockaday, Anna, Ow, Pei Loo, Hillmen, Peter, Rawstron, Andrew, Catovsky, Daniel, Bulian, Pietro, Bomben, Riccardo, Baird, Duncan M, Fegan, Christopher D, Gattei, Valter and Pepper, Chris (2021) Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies. Leukemia. pp. 1-4. ISSN 0887-6924

[img] PDF - Published Version
Available under License Creative Commons Attribution.

Download (733kB)
Item Type: Article
Schools and Departments: Brighton and Sussex Medical School > Clinical and Experimental Medicine
SWORD Depositor: Mx Elements Account
Depositing User: Mx Elements Account
Date Deposited: 30 Jun 2021 07:51
Last Modified: 30 Jun 2021 08:00
URI: http://sro.sussex.ac.uk/id/eprint/100090

View download statistics for this item

📧 Request an update